These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23265089)

  • 41. Peak experiences of psilocybin users and non-users.
    Cummins C; Lyke J
    J Psychoactive Drugs; 2013; 45(2):189-94. PubMed ID: 23909006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The danger of hallucinogenic mushrooms.
    Mills PR; Lesinskas D; Watkinson G
    Scott Med J; 1979 Oct; 24(4):316-7. PubMed ID: 555819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.
    Kopra EI; Ferris JA; Winstock AR; Kuypers KP; Young AH; Rucker JJ
    J Psychopharmacol; 2023 Jul; 37(7):733-748. PubMed ID: 36876583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hallucinogenic mushroom use by Danish students: pattern of consumption.
    Lassen JF; Lassen NF; Skov J
    J Intern Med; 1993 Feb; 233(2):111-2. PubMed ID: 8433070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in "grow-kits" seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocin.
    Gambaro V; Roda G; Visconti GL; Arnoldi S; Casagni E; Dell'Acqua L; Farè F; Paladino E; Rusconi C; Arioli S; Mora D
    J Pharm Biomed Anal; 2016 Jun; 125():427-32. PubMed ID: 27021629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Relations between usage of marihuana and other drugs among teenagers].
    Jurgaitiene D; Targamadze V
    Medicina (Kaunas); 2006; 42(10):843-51. PubMed ID: 17090985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants.
    Kaloyanides KB; McCabe SE; Cranford JA; Teter CJ
    Pharmacotherapy; 2007 May; 27(5):666-74. PubMed ID: 17461701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Substance use initiation: the role of simultaneous polysubstance use.
    Olthuis JV; Darredeau C; Barrett SP
    Drug Alcohol Rev; 2013 Jan; 32(1):67-71. PubMed ID: 22612987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
    Griffiths RR; Hurwitz ES; Davis AK; Johnson MW; Jesse R
    PLoS One; 2019; 14(4):e0214377. PubMed ID: 31013281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of perceived parenting style on the propensity for illicit drug use: the importance of parental warmth and control.
    Montgomery C; Fisk JE; Craig L
    Drug Alcohol Rev; 2008 Nov; 27(6):640-9. PubMed ID: 18821098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlates of drug use and driving among undergraduate college students.
    Kohn C; Saleheen H; Borrup K; Rogers S; Lapidus G
    Traffic Inj Prev; 2014; 15(2):119-24. PubMed ID: 24345012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Forensic analysis of hallucinogenic mushrooms and khat (Catha edulis Forsk) using cation-exchange liquid chromatography.
    Laussmann T; Meier-Giebing S
    Forensic Sci Int; 2010 Feb; 195(1-3):160-4. PubMed ID: 20047807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hallucinogenic mushrooms and psilocybine].
    DEYSSON G
    Proc Pharm Soc Egypt; 1960 Jan; 15():27-9. PubMed ID: 24546366
    [No Abstract]   [Full Text] [Related]  

  • 56. Psychedelic microdosing benefits and challenges: an empirical codebook.
    Anderson T; Petranker R; Christopher A; Rosenbaum D; Weissman C; Dinh-Williams LA; Hui K; Hapke E
    Harm Reduct J; 2019 Jul; 16(1):43. PubMed ID: 31288862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ilicit drugs frequently used by drug addicts].
    Cirriez JP
    J Pharm Belg; 2015 Mar; (1):8-15. PubMed ID: 26571792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications.
    Hyde C; Glancy G; Omerod P; Hall D; Taylor GS
    Br J Psychiatry; 1978 Jun; 132():602-4. PubMed ID: 566144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response of cluster headache to psilocybin and LSD.
    Sewell RA; Halpern JH; Pope HG
    Neurology; 2006 Jun; 66(12):1920-2. PubMed ID: 16801660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hallucinogen-induced psychological disorders].
    Hermle L; Kovar KA; Hewer W; Ruchsow M
    Fortschr Neurol Psychiatr; 2008 Jun; 76(6):334-42. PubMed ID: 18512184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.